Formulation Development and Evaluation of Extended Release Dosage form of Cilostazol for Treathment of Intermittent Chau

محفوظ في:

التفاصيل البيبلوغرافية
المؤلف الرئيسي:	Desai Chirag T.
التنسيق:	أطروحة كتاب
اللغة:	الإنجليزية
منشور في:	Mumbai NMIMS-SPPSPTM 2015
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELESES DOSAGE FORM OF CLIOSTAZOL FOR TREATMENT OF INTERMITTENT CLAUD
حسب: DESAI CHIRAG

FORMULATION AND EVALUATION OF EXTENDED RELEASE SOLID ORAL DOSAGE FORM OF DRUG X
حسب: DESAI RAVI

FORMULATION DEVELOPMENT AND EVALUATION OF AN EXTENDED RELEASE DOSAGE FOR MOF AN ANTIHYPERTENSIVE AGENTS
حسب: PATEL HITESH

Development and Evaluation of Extended Release Dosage Forms of Anti-Diabetic Drugs
حسب: Srivastav Monika
منشور في: (2012)

PREPARATION AND EVALUATION OF LORNOXICAM EXTENDED RELEASE FORMULATION
حسب: NAVANDAR SHRADDHA

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE ANTI-ANGINAL TABLETS
حسب: CHOKSHI DWEEP

FORMULATION DEVELOPMENT AND EVALUATION OF BUPROPION HYDROCHLORIDE EXTENDED RELEASE TABLETS
حسب: PATADE PRAGATI

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE CAPSULE OF TOLTERODINE TARTRATE
حسب: PATEL JAIMINKUMAR

DEVELOPMENT & FORMULATION OF?.DOSAGE FORMS
حسب: HARDEE GREGORY E (ED.)

FORMULATION AND DEVELOPMENT OF ANTICONVULSANT EXTENDED RELEASE TABLETS
حسب: PATEL KARISHMA

FORMULATION, DEVELOPMENT AND IN-VITRO EVALUATION OF EXTENDED RELEASE CAPSULES BY WURSTER TECHNOLOGY
حسب: DUDANI KEYUR

FORMULATION DEVELOPMENT AND EVALUATION OF AN EXTENDED RELEASE GASTRORETENTIVE TABLETS FOR AN ANTIHYPERTENSIVE DRUG
حسب: JAIN ABHISHEK

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF AN ANTI-HYPERTENSIVE DRUG
حسب: KOTHARI HARSH

FORMULATION AND EVALUATION OF ISOSORBIDE-5- MONONITRATE EXTENDED RELEASE TABLET
حسب: PATIL GAURAV

DEVELOPMENT AND EVALUATION OF ONCE A DAILY ORAL DOSAGE FORM OF LAMOTRIGINE
حسب: SHAH CHIRAG

DEVELOPMENT AND FORMULATION OF VETERNIARY DOSAGE FORMS
حسب: HARDEE GREGORY E [E], BAGGOT J DESMOND [E]
منشور في: (1998)

FORMULATION AND EVALUATION OF SODIUM VALPROATE AND VALPROIC ACID EXTENDED RELEASE TABLET
حسب: DAFTARY ADITI

FORMULATION AND EVALUATION OF EXTENDED RELEASE MATRIX TABLET OF HIGHLY SOLUBLE DRUG
حسب: DAFTARDAR SALONI

TO ENHANCE THE SOLUBILITY AND DEVELOP THE LIPOSOMES OF CILOSTAZOL
حسب: JAGTAP HRISHIKESH

PREPARATION AND EVALUATION OF FELODIPINE EXTENDED RELEASE CAPSULES
حسب: VIJAYAN VIVEK

FORMULATION AND EVALUATION OF NEW OPHTHALMIC DOSAGE FORM OF GATIFLOXACIN
حسب: PALKAR MAYURESH

CONTROLLED RELEASE DOSAGE FORM DESIGN
حسب: CHERNG -JU KIM
منشور في: (2000)

FORMULATION DEVELOPMENT AND EVALUATION OF DELAYED RELEASE TABLET FORMULATION
حسب: SHAH SNEHAL

FORMULATION DEVELOPMENT AND EVALUATION OF FIXED DOSE COMBINATION FOR HYPERTENSION
حسب: DESAI CHIRAG

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS OF HIGHLY WATER SOLUBLE DRUG X
حسب: SHAHI JAYA

FORMULATION PROCESS DEVELOPMENT AND EVALUATION OF FILM COATED ANTIEPILEPTIC EXTENDED RELEASE MATRIX TABLET
حسب: SHAH BHAUMIK

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE MULTIPARTICULATE DRUG DELIVERY SYSTEMS CONTAINING AN ANTIADRE
حسب: RUSTAGI DOLLY

Science of intermittent fasting
حسب: Vanderschelden, M
منشور في: (2019)

FORMULATION AND EVALUATION OF FELODIPINE EXTENDED RELEASE TABLETS BY HOT MELT GRANULATION METHOD
حسب: PRIYADARSHI JIGAR

FORMULATION DEVELOPMENT AND EVALUATION OF EXTENDED RELEASE TABLETS CONTAINING ANTI-PSYCHOTIC AGENT DRUG 'X'
حسب: DUBEY POOJA

FORMULATION DEVELOPMENT AND EVALUATION OF A BILAYER EXTENDED RELEASE TABLET CONTAINING ANALGESIC AND ANTIPYRETIC AGENTS
حسب: PAWAR VIKAS

FORMULATION DEVELOPMENT AND EVALUATION OF XYZ/ABC EXTENDED RELEASE BILAYER TABLETS CONTAINING ANTIHYPERTENSIVE AGENTS
حسب: HELGAR KISHORE

FORMULATION AND DEVELOPMENT OF EXTENDED RELEASE TABLETS OF A B-BLOCKING AGENT
حسب: RAKSHIT PUSHPITA

FORMULATION AND DEVELOPMENT OF ANTI-PARKINSON DRUG-X EXTENDED RELEASE TABLETS
حسب: PATEL KRUTI

FORMULATION DEVELOPMENT AND EVALUATION OF ORAL SOLID DOSAGE FORM CONTAINING AN ANTISYCHOTIC AGENT
حسب: MOHITE ASHISH

DEVELOPMENT AND EVALUATION OF ABT 01 EXTENDED RELEASE TABLET AS PER USP
حسب: DAVE SHIVAM

FORMULATION AND DEVELOPMENT OF LIQUID DOSAGE FORM LEVOFLOXACIN HEMIHYDRATE
حسب: PIYUSH PATEL

FORMULATION AND EVALUATION OF PROLIPOSOMES OF BENDAMUSTINE HYDROCHLORIDE INTO A POWDER DOSAGE FORM
حسب: YADAV INDU

FORMULATION DEVELOPMENT AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF AN ANTIDIABETIC DRUG A
حسب: DESAI NEEL

FORMULATION AND EVALUATION OF BILAYERED TABLET OF TRIMETAZIDINE DIHYDROCHLORIDE 35mg EXTENDED RELEASE AND METOPROLOL TAR
حسب: PATIL NISHA